Event chart 10X GENOMICS, INC. |
|
|
Upcoming events on 10X GENOMICS, INC. |
|
02/15/23 | | FY 2022 Earnings Release |
02/15/23 | 04:30pm | | FY 2022 Earnings Call |
05/03/23 | | Q1 2023 Earnings Release (Projected) |
08/02/23 | | Interim 2023 Earnings Release (Projected) |
11/01/23 | | Q3 2023 Earnings Release (Projected) |
02/14/24 | | FY 2023 Earnings Release (Projected) |
|
Past events on 10X GENOMICS, INC. |
|
01/10/23 | 08:15pm | | JP Morgan Healthcare Conference - Panel |
01/09/23 | 10:30am | | JP Morgan Healthcare Conference |
12/08/22 | 12:00pm | | Investor Day |
11/02/22 | 03:30pm | | Q3 2022 Earnings Call |
11/02/22 | 03:05pm | | Q3 2022 Earnings Release |
09/13/22 | 10:35am | | Morgan Stanley Global Healthcare Conference |
08/11/22 | 12:00pm | | UBS Genomics 2.0 and MedTech Innovations Summit |
08/08/22 | 04:30pm | | Interim 2022 Earnings Call |
08/08/22 | | Interim 2022 Earnings Release |
06/15/22 | 04:30pm | | Annual General Meeting |
|
Past dividends on 10X GENOMICS, INC. |
|
- No events available -
|
|
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread |
| 246 240 2,3% | 299 287 4,2% | 490 494 -0,65% | 508 |
Operating income (EBITDA) M $ |
Released Forecast Spread |
| -23,5 -27,6 15% | -520 -134 -288% | -31,1 -27,4 -14% | -161 |
Operating profit (EBIT) M $ |
Released Forecast Spread |
| -30,6 -34,5 11% | -86,6 -144 40% | -52,9 -49,4 -7,1% | -182 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread |
| -31,0 -39,0 20% | -534 -141 -278% | -53,7 -45,9 -17% | -182 |
Net income M $ |
Released Forecast Spread | -112
| -31,3 -37,1 16% | -543 -156 -247% | -58,2 -46,2 -26% | -184 |
EPS $ |
Released Forecast Spread | -8,40
| -0,80 -0,38 -112% | -5,37 -1,51 -255% | -0,53 -0,46 -16% | -1,63 | Announcement Date | 08/19/2019 | 02/18/2020 | 02/17/2021 | 02/16/2022 | - |
|
|
Fiscal Period : December | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
Sales M $ |
Released Forecast Spread | 71,8 61,2 17% | 112 100 12% | 106 103 3,0% | 116 113 2,7% | 125 123 2,0% | 144 148 -3,3% | 114 113 1,0% | 115 116 -1,1% | 131 129 1,5% | 148 | 136 | 146 | 159 | 179 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -61,7 -29,2 -111% | -406 -44,7 -807% | -5,27 -29,7 82% | -5,44 -21,9 75% | -10,2 -21,2 52% | -10,0 -4,00 -151% | -35,5 -36,1 1,4% | -56,6 -34,0 -67% | -33,8 -41,8 19% | -31,1 | -24,2 | -25,1 | -29,2 | -33,0 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -24,3 -32,1 24% | -2,67 -28,5 91% | -10,2 -25,9 61% | -11,2 -29,1 62% | -15,9 -24,8 36% | -15,8 -7,95 -99% | -41,7 -36,1 -16% | -63,1 -43,6 -45% | -40,0 -50,5 21% | -35,7 | -36,1 | -31,4 | -28,0 | -33,3 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -65,3 -35,8 -82% | -409 -14,9 -2 642% | -11,1 -32,1 65% | -9,96 -32,8 70% | -16,6 -27,6 40% | -16,0 -7,00 -128% | -41,7 -41,0 -1,7% | -63,8 -42,6 -50% | -40,0 -57,0 30% | -37,1 | -27,5 | -28,4 | -32,5 | -36,3 |
Net income M $ |
Released Forecast Spread | -65,8 -32,6 -102% | -416 -29,3 -1 317% | -11,6 -34,8 67% | -11,1 -35,0 68% | -17,2 -22,4 23% | -18,4 -4,85 -281% | -42,4 -37,3 -14% | -64,5 -43,7 -47% | -41,9 -50,5 17% | -33,8 | -22,8 | -23,6 | -27,0 | -30,1 |
EPS $ |
Released Forecast Spread | -0,65 -0,31 -109% | -3,87 -0,23 -1 603% | -0,11 -0,28 60% | -0,10 -0,26 62% | -0,15 -0,20 25% | -0,16 -0,08 -112% | -0,38 -0,31 -22% | -0,57 -0,36 -58% | -0,37 -0,48 23% | -0,32 | -0,34 | -0,32 | -0,28 | -0,23 | Announcement Date | 11/10/2020 | 02/17/2021 | 05/05/2021 | 08/04/2021 | 11/03/2021 | 02/16/2022 | 05/04/2022 | 08/08/2022 | 11/02/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for 10X GENOMICS, INC. |
|
|
|
Past sector events for 10X GENOMICS, INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|